Blood-Borne RNA Correlates with Disease Activity and IFN-Stimulated Gene Expression in Systemic Lupus Erythematosus.

导出原文传递

翻译打印收藏纠错

第一作者： John R,Doedens

第一单位： Resolve Therapeutics, LLC, Seattle, WA 98103;

作者： John R,Doedens ^[1] ; Wendell D,Jones ^[2] ; Kay,Hill ^[3] ; Michael J,Mason ^[4] ; Vivian H,Gersuk ^[5] ; Philip J,Mease ^[6] ; Maria,Dall'Era ^[7] ; Cynthia,Aranow ^[8] ; Richard W,Martin ^[9] ; Stanley B,Cohen ^[10] ; Roy M,Fleischmann ^[10] ; Alan J,Kivitz ^[11] ; Daniel J,Burge ^[1] ; Damien,Chaussabel ^[12] ; Keith B,Elkon ^[13] ; James A,Posada ^[14]

作者单位： Resolve Therapeutics, LLC, Seattle, WA 98103; ^[1] EA Genomics/Q Solutions, Durham, NC 27703; ^[2] PlasmaLab International, Everett, WA 98201; ^[3] Sage Bionetworks, Seattle, WA 98109; ^[4] Benaroya Research Institute, Seattle, WA 98101; ^[5] Swedish Medical Center and University of Washington, Seattle, WA 98122; ^[6] University of California, San Francisco, San Francisco, CA 94143; ^[7] The Feinstein Institute for Medical Research, Manhasset, NY 11030; ^[8] College of Human Medicine, Michigan State University, East Lansing, MI 48824; ^[9] Metroplex Clinical Research Center, Dallas, TX 75231; ^[10] Altoona Center for Clinical Research, Duncansville, PA 16635; ^[11] Benaroya Research Institute, Seattle, WA 98101; Sidra Medical and Research Center, Doha, Qatar; and. ^[12] Department of Rheumatology, University of Washington, Seattle, WA 98109. ^[13] Resolve Therapeutics, LLC, Seattle, WA 98103; jp@resolvebio.com. ^[14]